For many orthopedic conditions, surgery has traditionally been considered the definitive treatment. Procedures such as joint replacement, ligament reconstruction, or spinal surgery can provide relief for certain structural problems.
However, surgery is not always the first or only option. In recent years, regenerative medicine approaches such as mesenchymal stem cell (MSC) therapy have been explored as a potential way to support tissue repair and reduce inflammation before moving to surgical intervention.
This raises an important question for many patients: When should stem cell therapy be considered before surgery?
The answer depends on several factors, including the severity of the condition, the type of tissue damage, and the patient’s overall health.
When Surgery Is Clearly Necessary
In some situations, surgery remains the most appropriate treatment and regenerative therapies are unlikely to replace it. Examples include:
- Complete ligament rupture requiring reconstruction
- Advanced joint deformity with bone-on-bone collapse
- Severe spinal instability
- Fractures requiring mechanical stabilization
In these cases, the structural problem is too significant for biological therapies alone to resolve. Surgical correction may be necessary to restore mechanical stability before any regenerative treatments can be considered.
Situations Where Stem Cell Therapy May Be Considered First
Stem cell therapy may be considered when the joint or tissue still has enough structural integrity to respond to biological repair signals. Some examples include:
- Early to moderate osteoarthritis
- Partial ligament or tendon injuries
- Chronic joint inflammation
- Degenerative disc disease without severe instability
- Persistent joint pain despite conservative treatments
In these cases, the goal is not to replace tissue surgically but to improve the biological environment of the joint, potentially reducing inflammation and supporting tissue repair.
Why Many Patients Try Conservative Options First
Orthopedic medicine generally follows a stepwise treatment approach, starting with less invasive therapies before considering surgery.
Typical progression may include:
- Physical therapy and rehabilitation
- Anti-inflammatory medications
- Corticosteroid or hyaluronic acid injections
- Platelet-rich plasma (PRP) therapy
- Regenerative therapies such as Stem Cells MSCs
- Surgical intervention if necessary
The goal of this approach is to preserve the natural joint whenever possible. Surgery, while effective in many cases, carries risks such as infection, long recovery periods, and potential complications related to implants or hardware.
Why Some Patients Want to Delay Surgery
Joint surgeries such as knee replacement or spinal fusion can be highly effective, but they are also major procedures with significant recovery time. For example:
- Knee replacement recovery may take several months
- Joint implants have a limited lifespan
- Revision surgeries may be required later in life
- Some patients may not be ideal surgical candidates due to age or medical conditions
Because of these factors, some patients explore regenerative treatments to delay surgery or manage symptoms while maintaining joint function.
How Stem Cells Work in Degenerative Conditions
Mesenchymal stem cells do not function like a mechanical replacement for damaged tissue. Instead, research suggests that their primary effects occur through paracrine signaling, meaning the cells release bioactive molecules that influence the surrounding environment. These signals may help:
- Reduce inflammatory activity
- Modulate immune responses
- Support tissue repair processes
- Improve the joint microenvironment
Because of this mechanism, stem cell therapy is typically more suitable for inflammatory or degenerative conditions rather than structural collapse.
Understanding the Limitations
It is important to understand that stem cell therapy is not a universal alternative to surgery. Limitations include:
- Severe structural damage may not respond
- Results can vary between patients
- Multiple factors influence treatment outcomes
- Long-term data is still evolving for some conditions
Responsible regenerative medicine focuses on appropriate patient selection rather than replacing surgery in every situation.
When Doctors May Suggest Stem Cell Therapy
A physician may consider regenerative treatment if:
- Conservative treatments have failed
- Imaging shows moderate degeneration but not complete joint collapse
- The patient wishes to delay surgery
- There are medical reasons surgery carries higher risk
- The goal is to preserve natural joint tissue as long as possible
In these situations, stem cell therapy may be considered part of a broader joint preservation strategy.
The Future of Joint Preservation
Orthopedic medicine is gradually shifting toward approaches that aim to protect and preserve existing tissues before surgical intervention becomes necessary.
While surgery will always remain essential for certain conditions, regenerative medicine is expanding the range of options available to patients.
Understanding when each approach is appropriate allows physicians to create individualized treatment strategies that balance safety, effectiveness, and long-term joint health.
About EDNA Wellness
EDNA Wellness is a private Stem Cell Clinic and Regenerative Medicine Center in Bangkok, Thailand, specializing in Umbilical cord–derived Mesenchymal Stem Cells (UC-MSCs) for knee osteoarthritis and joint pain, stroke and other neuro-related conditions, and stem cell IV infusions for longevity and healthy aging. All treatments are doctor-designed and performed in a sterile clinical setting
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Shapiro SA, et al. A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. https://journals.sagepub.com/doi/10.1177/0363546516662455
- Malige A, Ribeiro M, Abdallah MN, et al. Mesenchymal stem cells in orthopaedics: A systematic review of clinical evidence, safety, and applications. https://pubmed.ncbi.nlm.nih.gov/39035449/
- Maheshwer B, Polce EM, Paul K, et al. Regenerative Potential of Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis and Chondral Defects https://pubmed.ncbi.nlm.nih.gov/32497658/
- Kim SH, Ha CW, Park YB, et al. Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee https://pubmed.ncbi.nlm.nih.gov/30756165/